We invest in software-based companies (Healthcare IT, tech-enabled services) operating in the US market and focus on B2B or B2B2C companies.
We are looking for products that solve a real unmet need and have clear cost saving or revenue generating aspect.
We seek to leverage Arkin’s extensive cross sector exposure, especially in the crossroads between pharmaceutical / biotech, devices and digital health to support our portfolio companies and create new value propositions.

More color on our thoughts and approach at: “Differential Diagnosis”, Arkin’s Digital Health blog

Visit Our Blog